Health Barrow Women’s Board reaches milestone of $100M raised through Barrow Grand Ball James Pereira Jan 28, 2023 <!-- Name:DistributionId Value:8738189 --> <!--… Read More...
Health AIIMS Delhi Drop Service: Cardio neurosciences patients at Delhi AIIMS to get free drop service,… James Pereira Jan 23, 2023 New Delhi: In an initiative to provide better medical care, All India Institute of Medical Sciences's cardio… Read More...
Health Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the… James Pereira Dec 28, 2022 BURLINGTON, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage… Read More...
Business JMP Securities Downgrades Minerva Neurosciences to Market Perform Nick J Adam Oct 17, 2022 JMP Securities Downgrades Minerva Neurosciences to Market Perform Stay connected with us on social media platform… Read More...
Health ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results James Pereira Aug 16, 2022 TORONTO, Ontario and CAMBRIDGE, Massachusetts, Aug. 15, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX:… Read More...
Health CARE acquires Indore’s specialty hospital CHL – ET HealthWorld James Pereira Jul 4, 2022 Private equity fund TPG-backed CARE Hospitals has acquired Indore-based CHL Hospitals, the first corporate hospital… Read More...
Health Barrow Neurological Institute opens major new neuroscience facility James Pereira Apr 20, 2022 PHOENIX, April 19, 2022 (GLOBE NEWSWIRE) -- Barrow Neurological Institute has officially opened a new neuroscience… Read More...
Health Minerva Neurosciences Announces FDA Recommendation for Type C Meeting to Discuss Evidence for Use of… James Pereira Nov 3, 2021 WALTHAM, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage… Read More...
Health ProMIS Neurosciences re-initiates path to IND for PMN310 with producer cell line development James Pereira May 23, 2021 TORONTO and CAMBRIDGE, Mass., May 21, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF),… Read More...